Endothelial mitogen-activated protein kinase kinase kinase kinase 4 is critical for lymphatic vascular development and function

Molecular and Cellular Biology

Volumn 36, Issue 12, 2016, Pages 1740-1749

  Roth Flach, Rachel J ^a,b   Guo, Chang An ^a,c   Danai, Laura V ^a,d   Yawe, Joseph C ^a   Gujja, Sharvari ^a   Edwards, Yvonne J K ^a   Czech, Michael P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINODACTINOMYCIN; ALBUMIN; CHOLESTEROL; CHYLOMICRON; FIBRINOGEN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; PLASMA PROTEIN; PROTEIN P21; RAS PROTEIN; TRIACYLGLYCEROL; VASCULAR ENDOTHELIAL CADHERIN; MAP4K4 PROTEIN, HUMAN; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CAPILLARY; CARDIOVASCULAR FUNCTION; CELL FATE; CELL INTERACTION; CELL PROLIFERATION; CHYLE; CHYLOTHORAX; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DEVELOPMENT; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LETHALITY; LYMPH FLOW; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; THORACIC CAVITY; ANIMAL; CELL LINE; GENETICS; MORTALITY; NEWBORN; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANIMALS, NEWBORN; CELL LINE; CELL PROLIFERATION; CHYLOTHORAX; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC VESSELS; MICE; PROTEIN-SERINE-THREONINE KINASES;

EID: 84971472477     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01121-15     Document Type: Article

References (39)

1. Choi I, Lee S, Hong YK. 2012. The new era of the lymphatic system: no longer secondary to the blood vascular system. Cold Spring Harb Perspect Med 2:a006445. http://dx.doi.org/10.1101/cshperspect.a006445.
2. Randolph GJ, Miller NE. 2014. Lymphatic transport of high-density lipoproteins and chylomicrons. J Clin Invest 124:929-935. http://dx.doi.org/10.1172/JCI71610.
3. Card CM, Yu SS, Swartz MA. 2014. Emerging roles of lymphatic endothelium in regulating adaptive immunity. J Clin Invest 124:943-952. http://dx.doi.org/10.1172/JCI73316.
4. Alitalo K. 2011. The lymphatic vasculature in disease. Nat Med 17:1371-1380. http://dx.doi.org/10.1038/nm.2545.
5. Wang Y, Oliver G. 2010. Current views on the function of the lymphatic vasculature in health and disease. Genes Dev 24:2115-2126. http://dx.doi.org/10.1101/gad.1955910.
6. Wigle JT, Oliver G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98:769-778. http://dx.doi.org/10.1016/S0092-8674(00)81511-1.
7. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21:1505-1513. http://dx.doi.org/10.1093/emboj/21.7.1505.
8. Roth Flach RJ, Skoura A, Matevossian A, Danai LV, Zheng W, Cortes C, Bhattacharya SK, Aouadi M, Hagan N, Yawe JC, Vangala P, Menendez LG, Cooper MP, Fitzgibbons TP, Buckbinder L, Czech MP. 2015. Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis. Nat Commun 6:8995. http://dx.doi.org/10.1038/ncomms9995.
9. Alva JA, Zovein AC, Monvoisin A, Murphy T, Salazar A, Harvey NL, Carmeliet P, Iruela-Arispe ML. 2006. VE-cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn 235:759-767. http://dx.doi.org/10.1002/dvdy.20643.
10. Lapinski PE, Kwon S, Lubeck BA, Wilkinson JE, Srinivasan RS, Sevick-Muraca E, King PD. 2012. RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice. J Clin Invest 122:733-747. http://dx.doi.org/10.1172/JCI46116.
11. Baumgartner M, Sillman AL, Blackwood EM, Srivastava J, Madson N, Schilling JW, Wright JH, Barber DL. 2006. The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors. Proc Natl Acad Sci U S A 103:13391-13396. http://dx.doi.org/10.1073/pnas.0605950103.
12. Fitzgibbons TP, Kogan S, Aouadi M, Hendricks GM, Straubhaar J, Czech MP. 2011. Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am J Physiol Heart Circ Physiol 301:H1425-H1437. http://dx.doi.org/10.1152/ajpheart.00376.2011.
13. Mortimer PS, Rockson SG. 2014. New developments in clinical aspects of lymphatic disease. J Clin Invest 124:915-921. http://dx.doi.org/10.1172/JCI71608.
14. Petrova TV, Karpanen T, Norrmen C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Yla-Herttuala S, Miura N, Alitalo K. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10:974-981. http://dx.doi.org/10.1038/nm1094.
15. Bazigou E, Lyons OT, Smith A, Venn GE, Cope C, Brown NA, Makinen T. 2011. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest 121:2984-2992. http://dx.doi.org/10.1172/JCI58050.
16. Vitorino P, Yeung S, Crow A, Bakke J, Smyczek T, West K, McNamara E, Eastham-Anderson J, Gould S, Harris SF, Ndubaku C, Ye W. 2015. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility. Nature 519:425-430. http://dx.doi.org/10.1038/nature14323.
17. Su YC, Han J, Xu S, Cobb M, Skolnik EY. 1997. NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain. EMBO J 16:1279-1290. http://dx.doi.org/10.1093/emboj/16.6.1279.
18. Ger M, Zitkus Z, Valius M. 2011. Adaptor protein Nck1 interacts with p120 Ras GTPase-activating protein and regulates its activity. Cell Signal 23:1651-1658. http://dx.doi.org/10.1016/j.cellsig.2011.05.019.
19. Becker E, Huynh-Do U, Holland S, Pawson T, Daniel TO, Skolnik EY. 2000. Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation. Mol Cell Biol 20:1537-1545. http://dx.doi.org/10.1128/MCB.20.5.1537-1545.2000.
20. Burrows PE, Gonzalez-Garay ML, Rasmussen JC, Aldrich MB, Guilliod R, Maus EA, Fife CE, Kwon S, Lapinski PE, King PD, Sevick-Muraca EM. 2013. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. Proc Natl Acad Sci U S A 110:8621-8626. http://dx.doi.org/10.1073/pnas.1222722110.
21. King PD, Lubeck BA, Lapinski PE. 2013. Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis. Sci Signal 6:re1. http://dx.doi.org/10.1126/scisignal.2003669.
22. Deng Y, Atri D, Eichmann A, Simons M. 2013. Endothelial ERK signaling controls lymphatic fate specification. J Clin Invest 123:1202-1215. http://dx.doi.org/10.1172/JCI63034.
23. Simons M, Alitalo K, Annex BH, Augustin HG, Beam C, Berk BC, Byzova T, Carmeliet P, Chilian W, Cooke JP, Davis GE, Eichmann A, Iruela-Arispe ML, Keshet E, Sinusas AJ, Ruhrberg C, Woo YJ, Dimmeler S, American Heart Association Council on Basic Cardiovascular Sciences, Council on Cardiovascular Surgery and Anesthesia. 2015. State-of-the-art methods for evaluation of angiogenesis and tissue vascularization: a scientific statement from the American Heart Association. Circ Res 116:e99-e132. http://dx.doi.org/10.1161/RES.0000000000000054.
24. Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, Boyd K, Sleeman MW, Oliver G. 2005. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet 37: 1072-1081. http://dx.doi.org/10.1038/ng1642.
25. Lim HY, Rutkowski JM, Helft J, Reddy ST, Swartz MA, Randolph GJ, Angeli V. 2009. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration.AmJ Pathol 175:1328-1337. http://dx.doi.org/10.2353/ajpath.2009.080963.
26. Lim HY, Thiam CH, Yeo KP, Bisoendial R, Hii CS, McGrath KC, Tan KW, Heather A, Alexander JS, Angeli V. 2013. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BImediated transport of HDL. Cell Metab 17:671-684. http://dx.doi.org/10.1016/j.cmet.2013.04.002.
27. Martel C, Li W, Fulp B, Platt AM, Gautier EL, Westerterp M, Bittman R, Tall AR, Chen SH, Thomas MJ, Kreisel D, Swartz MA, Sorci-Thomas MG, Randolph GJ. 2013. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest 123:1571-1579. http://dx.doi.org/10.1172/JCI63685.
28. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5:74-80. http://dx.doi.org/10.1038/ni1013.
29. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. 2001. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 98:12677-12682. http://dx.doi.org/10.1073/pnas.221449198.
30. Makinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA. 2005. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19:397-410. http://dx.doi.org/10.1101/gad.330105.
31. Zhang G, Brady J, Liang WC, Wu Y, Henkemeyer M, Yan M. 2015. EphB4 forward signalling regulates lymphatic valve development. Nat Commun 6:6625. http://dx.doi.org/10.1038/ncomms7625.
32. Kawasaki J, Aegerter S, Fevurly RD, Mammoto A, Mammoto T, Sahin M, Mably JD, Fishman SJ, Chan J. 2014. RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity. J Clin Invest 124:2774-2784. http://dx.doi.org/10.1172/JCI67084.
33. Ichise T, Yoshida N, Ichise H. 2010. H-, N-and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice. Development 137:1003-1013. http://dx.doi.org/10.1242/dev.043489.
34. Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, Nye E, Stamp G, Alitalo K, Downward J. 2007. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell 129:957-968. http://dx.doi.org/10.1016/j.cell.2007.03.051.
35. Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosenthal A, Schafer R. 2000. A genome-wide survey of RAS transformation targets. Nat Genet 24:144-152. http://dx.doi.org/10.1038/72799.
36. Bajaj A, Zheng Q, Adam A, Vincent P, Pumiglia K. 2010. Activation of endothelial ras signaling bypasses senescence and causes abnormal vascular morphogenesis. Cancer Res 70:3803-3812. http://dx.doi.org/10.1158/0008-5472.CAN-09-2648.
37. Srinivasan R, Zabuawala T, Huang H, Zhang J, Gulati P, Fernandez S, Karlo JC, Landreth GE, Leone G, Ostrowski MC. 2009. Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS One 4:e8283. http://dx.doi.org/10.1371/journal.pone.0008283.
38. Ndubaku CO, Crawford TD, Chen H, Boggs JW, Drobnick J, Harris SF, Jesudason R, McNamara E, Nonomiya J, Sambrone A, Schmidt S, Smyczek T, Vitorino P, Wang L, Wu P, Yeung S, Chen J, Chen K, Ding CZ, Wang T, Xu Z, Gould SE, Murray LJ, Ye W. 2015. Structure-based design of GNE-495, a potent and selective MAP4K4 inhibitor with efficacy in retinal angiogenesis. ACS Med Chem Lett 6:913-918. http://dx.doi.org/10.1021/acsmedchemlett.5b00174.
39. Schroder P, Forster T, Kleine S, Becker C, Richters A, Ziegler S, Rauh D, Kumar K, Waldmann H. 2015. Neuritogenic militarinone-inspired 4-hydroxypyridones target the stress pathway kinase MAP4K4. Angew Chem Int Ed Engl 54:12398-12403. http://dx.doi.org/10.1002/anie.201501515.